Evidence map›Paper›PMID 40287740›Full record

ArticleVirology journal2025

Study on the detection rate, genetic polymorphism, viral load, persistent infection capacity, and pathogenicity of human papillomavirus type 33.

Qiongyao Li, Qichen Cheng, Di Tian, Zhengyuan An, Lei Li, Feng Yang, Mingjing Zhang, Ganglin Liu, A Peixin, Yan Yang and 1 more

Abstract read
In one paragraph

Article in Virology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Qiongyao Li *Department of Laboratory Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, 563000, China.
Qichen Cheng *Department of Laboratory Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, 563000, China.
Di TianDepartment of Laboratory Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, 563000, China.
Zhengyuan AnDepartment of Medical Laboratory, People's Hospital of Dejang, Dejang, Guizhou, China.
Lei LiInformation Division, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Feng YangInformation Division, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Mingjing ZhangLaboratory of Family Planning Service Center, Tongnan Maternal and Child Health Care Hospital, Tongnan, Chongqing, China.
Ganglin LiuDepartment of Laboratory Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, 563000, China.
A PeixinDepartment of Laboratory Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, 563000, China.
Yan YangDepartment of Laboratory Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, 563000, China. yanyangzmu@163.com.
Zuyi ChenDepartment of Laboratory Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, 563000, China. 514373742@qq.com.

Funding

Affiliated Hospital of Zunyi Medical University rc220220916College Students' Innovative Entrepreneurial Training Plan Program 2024106610893National Natural Science Foundation of China 82302527Natural Science Foundation of Guizhou Province xmrc120240204Zunyi Science and Big Data Bureau HZ (2023) 239
6 · The paper itself

Abstract

backgroundThere is a lack of research on the relations among genetic polymorphisms, viral load, adaptability, persistent infection ability, and pathogenicity of human papillomavirus (HPV) type 33. Understanding these relations is crucial for revealing its pathogenic mechanisms and formulating prevention strategies.

methodsExfoliated cervical cells were harvested from female participants in three hospitals located in the southwestern region of China (Guizhou, Sichuan, and Chongqing). Real-time fluorescence PCR technology was used for HPV genotyping and genomic quantification, and Sanger sequencing was used to obtain the gene sequence. then, changing trends in HPV33 detection rates and E6/E7 allele frequencies were compared. Positive selection, viral load, pathogenicity, and persistent infection capacity of different E6/E7 variants/mutations were analyzed.

resultsAmong 239,743 samples, HPV detection number was 56,681, the HPV33 detection rate was 3.72% (2,110/56,681) among all detected HPV genotypes. Between 2009 and 2023, a downward trend in the HPV33 detection rate was observed. The E6 + E7 prototype (E6 + E7 on the same variant is consistent with the reference sequence) was the dominant variant, with a significantly increased allele frequency. This dominant variant showed a significantly higher relative risk in causing persistent infection and cervical diseases (cervical intraepithelial neoplasia and cervical cancer). The viral load in the cervical disease group was significantly higher than that in the lesion-free group, and the viral load in the persistent infection group was significantly higher than that in the viral clearance group. There was no correlation between viral load and major genetic variants/mutations.

conclusionsThe E6 + E7 prototype has a significant impact on the pathogenicity and persistent infection capacity of HPV33. Viral load is positively correlated with pathogenicity and persistent infection capacity. It may serve as a biomarker for predicting disease progression during HPV33 screening. Other mechanisms underlying allele replacement require further investigation.

Indexed as

PapillomaviridaePapillomavirus InfectionsPersistent InfectionPolymorphism, GeneticViral LoadAdultAlphapapillomavirusCervix UteriChinaFemaleGene FrequencyGenotypeHuman Papillomavirus VirusesHumansMiddle AgedOncogene Proteins, ViralOncogene Proteins, ViralCervical cancerCervical intraepithelial neoplasiaHuman papillomavirusSingle nucleotide polymorphismsViral loadViral persistence

Identifiers

PMID40287740
PMCPMC12034117

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.